James P. Franciosi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James P. Franciosi has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Michael Spergel
Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
3 shared publications Alexandria J. Greenler
Division of Gastroenterology, Hepatology, and Nutrition Cincinnati OH
1 shared publicationAllison B. Greenberg
Division of Allergy and Immunology Cincinnati OH
1 shared publicationAnthony P. Olive
Department of Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Baylor College of Medicine Houston TX
1 shared publicationCarla M. Davis
Department of Pediatrics, Allergy, and Immunology Baylor College of Medicine Houston TX
1 shared publicationChris A Liacouras
The Children's Hospital of Philadelphia Division of Gastroenterology, Hepatology and Nutrition USA
1 shared publication
Latest Publications
- 1 July 2013
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 57 (1) , 57-66
PedsQL Eosinophilic Esophagitis Module
Objective: Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory condition with a paucity of information on health‐related quality of life (HRQOL). The objective of the study was to report on the measurement properties of the PedsQL EoE Module.Methods: The PedsQL EoE Module was completed in a multisite study by 196 pediatric patients with EoE and 262 parents of patients with EoE.Results: The PedsQL EoE Module scales evidenced excellent feasibility (0.6%–3.1% missing), excellent group comparison reliability across total scale scores (patient α 0.93; parent proxy α 0.94), good reliability for the 7 individual scales (patient α 0.75–0.87; parent proxy α 0.81–0.92), excellent test–retest reliability (patient intraclass correlation coefficient 0.88; parent intraclass correlation coefficient 0.82), demonstrated no floor effects and low ceiling effects, and demonstrated a high percentage of scaling success for most scales. Intercorrelations with the PedsQL Generic Core Scales were in the medium (0.30) to large (0.50) range. PedsQL EoE Module scores were worse among patients with active histologic disease (≥5 eos/hpf) compared with those in remission (patient self‐report: 63.3 vs 69.9 [P < 0.05]; parent proxy report: 65.1 vs 72.3 [P < 0.01]), and those treated with dietary restrictions compared with those with no restrictions (patient self‐report: 61.6 vs 74.3 [P < 0.01]; parent proxy report: 65.5 vs 74.7 [P < 0.01]).Conclusions: The results demonstrate excellent measurement properties of the PedsQL EoE Module. Patients with active histologic disease and those treated with dietary restrictions demonstrated worse PedsQL scores. The PedsQL EoE Module may be used in the evaluation of pediatric EoE disease‐specific HRQOL in clinical research and practice.
- 1 July 2013
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 57 (1) , 57-66
PedsQL Eosinophilic Esophagitis Module
Objective: Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory condition with a paucity of information on health‐related quality of life (HRQOL). The objective of the study was to report on the measurement properties of the PedsQL EoE Module.Methods: The PedsQL EoE Module was completed in a multisite study by 196 pediatric patients with EoE and 262 parents of patients with EoE.Results: The PedsQL EoE Module scales evidenced excellent feasibility (0.6%–3.1% missing), excellent group comparison reliability across total scale scores (patient α 0.93; parent proxy α 0.94), good reliability for the 7 individual scales (patient α 0.75–0.87; parent proxy α 0.81–0.92), excellent test–retest reliability (patient intraclass correlation coefficient 0.88; parent intraclass correlation coefficient 0.82), demonstrated no floor effects and low ceiling effects, and demonstrated a high percentage of scaling success for most scales. Intercorrelations with the PedsQL Generic Core Scales were in the medium (0.30) to large (0.50) range. PedsQL EoE Module scores were worse among patients with active histologic disease (≥5 eos/hpf) compared with those in remission (patient self‐report: 63.3 vs 69.9 [P < 0.05]; parent proxy report: 65.1 vs 72.3 [P < 0.01]), and those treated with dietary restrictions compared with those with no restrictions (patient self‐report: 61.6 vs 74.3 [P < 0.01]; parent proxy report: 65.5 vs 74.7 [P < 0.01]).Conclusions: The results demonstrate excellent measurement properties of the PedsQL EoE Module. Patients with active histologic disease and those treated with dietary restrictions demonstrated worse PedsQL scores. The PedsQL EoE Module may be used in the evaluation of pediatric EoE disease‐specific HRQOL in clinical research and practice.
- 1 October 2010
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 51 (4) , 443-447
Changing Indications for Upper Endoscopy in Children During a 20‐year Period
Objectives: In parallel with the increase in pediatric esophagogastroduodenoscopy (EGD) procedures since the 1970s, the incidence of disorders that require EGD for diagnosis in children has increased. The aim of this study was to identify changes in subject characteristics and endoscopic procedures during a 20‐year interval in children undergoing EGD at a single center.Patients and Methods: All of the children undergoing first EGD with biopsy in 1985, 1995, or 2005 were identified. Details of the clinical presentation and EGD were abstracted from medical records in a random sample of subjects within each time point.Results: The number of first‐time EGDs rose dramatically from 107 in 1985 to 1294 in 2005. The proportion of subjects that were younger than 1 year of age varied significantly from 13% in 1985 to 23% in 1995 and 8% in 2005 (P < 0.001). The proportion of subjects with gastrointestinal (GI) bleeding declined from 34% to 5% during the 20‐year interval (P < 0.001), whereas the proportion with abdominal pain increased from 23% to 43% (P < 0.01). During the same interval, the proportion of subjects with complete EGD (biopsies from the esophagus, stomach, and duodenum) increased from 18% of EGDs in 1985 to 95% in 2005 (P < 0.001).Conclusions: This study of children undergoing first‐time EGDs with biopsy during a 20‐year interval demonstrated significant differences in subject characteristics and endoscopy practices. The inclusion of children with less severe clinical presentation and the collection of greater numbers of biopsies per procedure may contribute to the rising incidence rates of pediatric GI disorders.
- 1 October 2010
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 51 (4) , 443-447
Changing Indications for Upper Endoscopy in Children During a 20‐year Period
Objectives: In parallel with the increase in pediatric esophagogastroduodenoscopy (EGD) procedures since the 1970s, the incidence of disorders that require EGD for diagnosis in children has increased. The aim of this study was to identify changes in subject characteristics and endoscopic procedures during a 20‐year interval in children undergoing EGD at a single center.Patients and Methods: All of the children undergoing first EGD with biopsy in 1985, 1995, or 2005 were identified. Details of the clinical presentation and EGD were abstracted from medical records in a random sample of subjects within each time point.Results: The number of first‐time EGDs rose dramatically from 107 in 1985 to 1294 in 2005. The proportion of subjects that were younger than 1 year of age varied significantly from 13% in 1985 to 23% in 1995 and 8% in 2005 (P < 0.001). The proportion of subjects with gastrointestinal (GI) bleeding declined from 34% to 5% during the 20‐year interval (P < 0.001), whereas the proportion with abdominal pain increased from 23% to 43% (P < 0.01). During the same interval, the proportion of subjects with complete EGD (biopsies from the esophagus, stomach, and duodenum) increased from 18% of EGDs in 1985 to 95% in 2005 (P < 0.001).Conclusions: This study of children undergoing first‐time EGDs with biopsy during a 20‐year interval demonstrated significant differences in subject characteristics and endoscopy practices. The inclusion of children with less severe clinical presentation and the collection of greater numbers of biopsies per procedure may contribute to the rising incidence rates of pediatric GI disorders.
- 1 April 2009
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 7 (4) , 415-419
A Case-Control Study of Sociodemographic and Geographic Characteristics of 335 Children With Eosinophilic Esophagitis
- 1 April 2009
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 7 (4) , 415-419
A Case-Control Study of Sociodemographic and Geographic Characteristics of 335 Children With Eosinophilic Esophagitis
- 1 February 2009
- Published by Elsevier in Digestive and Liver Disease
- Vol. 41 (2) , 123-126
Randomised controlled trial of paediatric magnetic positioning device assisted colonoscopy: A pilot and feasibility study
- 1 February 2009
- Published by Elsevier in Digestive and Liver Disease
- Vol. 41 (2) , 123-126
Randomised controlled trial of paediatric magnetic positioning device assisted colonoscopy: A pilot and feasibility study